Cellular & Molecular Immunology

Cellular & Molecular Immunology (CMI), abbreviated as *Cell Mol Immunol*, is a premier peer-reviewed journal dedicated to advancing the understanding of immune system mechanisms at the molecular, cellular, and organismal levels. With a 2026 Impact Factor of 23.900 and consistently placed in the JCR Q1 quartile, the journal stands among the top-tier publications in immunology and cell biology. Its scope encompasses a broad spectrum of topics, including innate and adaptive immunity, immune signaling pathways, inflammation, tumor immunology, autoimmunity, infectious disease immunology, and the development of immunotherapies. The journal publishes original research articles, comprehensive reviews, concise reports, and authoritative commentaries that highlight significant breakthroughs and emerging concepts. It is particularly valued for its rapid dissemination of high-impact findings that bridge basic immunological research with clinical translation. The target audience includes immunologists, molecular biologists, clinicians, and biomedical researchers seeking cutting-edge insights into immune regulation and disease mechanisms. Notable features of CMI include its open access model, ensuring global accessibility and high visibility for published work, and its publication under the auspices of Springer Nature in partnership with the Chinese Society of Immunology. The journal’s exceptional impact factor and Q1 ranking underscore its influential role in shaping the field, making it a must-read resource for those at the forefront of molecular and cellular immunology research.